Global Home Global Home  
 
 

News

Date Title and Summary Additional Formats
Toggle Summary Oculus Innovative Sciences Receives FDA Clearance for Novel Atopic Dermatitis Dermatology Product
PETALUMA, Calif. , June 8, 2015 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care, today announced that it has received a new 510(k)
View HTML
Toggle Summary Oculus Innovative Sciences Announces Fiscal Fourth Quarter 2015 Financial Results and Conference Call
PETALUMA, Calif. , May 28, 2015 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), today announced that the financial results for its fiscal fourth quarter 2015, ended March 31, 2015 , will be released after the U.S. markets close on June 11, 2015 .
View HTML
Toggle Summary Oculus Innovative Sciences Announces Launch of MicrocynAH(R) Farm and Ranch Animal Healthcare Products
Ten North American distributors have added MicrocynAH® animal healthcare products to their product portfolios since launch in February 2015 Antibiotic-free MicrocynAH® helps create an optimal wound healing environment without the use of antibiotics, better enabling farmers and ranchers to support
View HTML